Selection of Patients for Treatment of Brain Arteriovenous Malformations by the Transvenous Approach: Relationship with Venous Anatomy and Risk of Hemorrhagic Complications.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 06 2020
accepted: 04 08 2020
pubmed: 31 10 2020
medline: 9 3 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

Intracranial hemorrhage represents a severe complication of brain arteriovenous malformation treatment. The aim of this cohort was to report the rate of hemorrhagic complications after transvenous endovascular embolization and analyze the potential angioarchitectural risk factors as well as clinical outcomes. During an 11-year period, 57 patients underwent transvenous endovascular embolization. All cases of hemorrhagic complications were identified. We analyzed the following variables: sex, age, hemorrhagic presentation, Spetzler-Martin grade, size of the AVM before the transvenous treatment, number of venous collectors, pattern of drainage, presence of dilated veins, and technical aspects. Univariate and multivariate multiple regression analyses were performed to evaluate the potential risk factors for procedure-related hemorrhagic complications. Hemorrhagic complications (either intraprocedural or periprocedural) unrelated to a perforation due to micronavigation occurred in 8 (14.0%) procedures. Significant (mRS > 2) and persistent neurologic deficits were present in 2 (3.5%) patients at 6-month control. Larger nidi, especially >3 cm ( Larger nidus sizes and an increased number of venous collectors may increase the risk of hemorrhagic complications when implementing transvenous endovascular treatment of AVMs. The technique is effective and promising, especially with small nidi and single venous collectors.

Sections du résumé

BACKGROUND AND PURPOSE
Intracranial hemorrhage represents a severe complication of brain arteriovenous malformation treatment. The aim of this cohort was to report the rate of hemorrhagic complications after transvenous endovascular embolization and analyze the potential angioarchitectural risk factors as well as clinical outcomes.
MATERIALS AND METHODS
During an 11-year period, 57 patients underwent transvenous endovascular embolization. All cases of hemorrhagic complications were identified. We analyzed the following variables: sex, age, hemorrhagic presentation, Spetzler-Martin grade, size of the AVM before the transvenous treatment, number of venous collectors, pattern of drainage, presence of dilated veins, and technical aspects. Univariate and multivariate multiple regression analyses were performed to evaluate the potential risk factors for procedure-related hemorrhagic complications.
RESULTS
Hemorrhagic complications (either intraprocedural or periprocedural) unrelated to a perforation due to micronavigation occurred in 8 (14.0%) procedures. Significant (mRS > 2) and persistent neurologic deficits were present in 2 (3.5%) patients at 6-month control. Larger nidi, especially >3 cm (
CONCLUSIONS
Larger nidus sizes and an increased number of venous collectors may increase the risk of hemorrhagic complications when implementing transvenous endovascular treatment of AVMs. The technique is effective and promising, especially with small nidi and single venous collectors.

Identifiants

pubmed: 33122201
pii: ajnr.A6810
doi: 10.3174/ajnr.A6810
pmc: PMC7963238
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2311-2316

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

Neurosurgery. 1995 Jul;37(1):29-35; discussion 35-6
pubmed: 8587687
J Neurosurg. 2011 Jul;115(1):78-88
pubmed: 21476804
J Neurosurg. 2015 May;122(5):1229-38
pubmed: 25794338
J Neurosurg. 2017 Apr;126(4):1056-1063
pubmed: 27285541
World Neurosurg. 2014 Sep-Oct;82(3-4):386-94
pubmed: 24657255
J Neurosurg. 2019 Sep 13;:1-11
pubmed: 31518979
Neurosurgery. 2015 Oct;77(4):644-51; discussion 652
pubmed: 26120797
J Neurosurg. 2017 Nov;127(5):1025-1040
pubmed: 27982772
Neurosurgery. 2006 Apr;58(4):602-11; discussion 602-11
pubmed: 16575323
Neurosurgery. 1999 Aug;45(2):351-63; discussion 363-5
pubmed: 10449081
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):547-54
pubmed: 9771782
Acta Neurochir (Wien). 2002 Sep;144(9):879-87; discussion 888
pubmed: 12376769
AJNR Am J Neuroradiol. 2013 Sep;34(9):1805-11
pubmed: 23557955
Stroke. 2002 Jul;33(7):1816-20
pubmed: 12105359
Neurosurgery. 2016 Mar;78(3):458-65
pubmed: 26457485
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jan;64(1):23-30
pubmed: 11310368
Neurosurg Focus. 2018 Jul;45(1):E13
pubmed: 29961383
AJNR Am J Neuroradiol. 2014 May;35(5):978-83
pubmed: 24676002
Neurocrit Care. 2019 Oct;31(2):346-356
pubmed: 30767121
Neurosurgery. 2018 Nov 1;83(5):957-964
pubmed: 29281075
J Neurointerv Surg. 2016 Mar;8(3):265-72
pubmed: 25540177
Neuroradiology. 2001 Aug;43(8):662-71
pubmed: 11548175
AJNR Am J Neuroradiol. 2006 Jan;27(1):162-76
pubmed: 16418378
Surg Neurol. 1990 Sep;34(3):188-95
pubmed: 2385826
J Neurosurg. 2006 Feb;104(2):226-32
pubmed: 16509496
Neurosurg Rev. 2015 Jul;38(3):399-404; discussion 404-5
pubmed: 25483235
AJNR Am J Neuroradiol. 2014 Feb;35(2):354-9
pubmed: 23886744

Auteurs

J M B De Sousa (JMB)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France jorgemurilobs@gmail.com.

C Iosif (C)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

L Z Sganzerla (LZ)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

A N Rafie (AN)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

V Borodetsky (V)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

A Rouchaud (A)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

S Saleme (S)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

C Mounayer (C)

From the Department of Interventional Neuroradiology, Hôpital Dupuytren, Centre Regional Hospitalier Universitaire de Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH